Barclays Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $25.00

Aspen Aerogels (NYSE:ASPN) had its price target cut by Barclays from $27.00 to $25.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the construction company’s stock. Barclays‘s target price would suggest a potential upside of 60.88% from the company’s previous close.

Other research analysts also recently issued reports about the company. TD Cowen boosted their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Benchmark reissued a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research report on Thursday, October 31st. Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Finally, Piper Sandler decreased their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $15.54 on Tuesday. Aspen Aerogels has a twelve month low of $9.57 and a twelve month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.28 billion, a PE ratio of 1,555.56 and a beta of 2.21. The company’s 50 day moving average is $22.66 and its 200 day moving average is $24.74.

Insiders Place Their Bets

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently made changes to their positions in ASPN. Point72 Hong Kong Ltd purchased a new stake in Aspen Aerogels during the 2nd quarter valued at approximately $84,000. nVerses Capital LLC acquired a new position in shares of Aspen Aerogels in the second quarter worth $95,000. Quent Capital LLC acquired a new position in Aspen Aerogels in the 3rd quarter valued at about $118,000. Point72 DIFC Ltd acquired a new stake in Aspen Aerogels during the second quarter worth approximately $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in Aspen Aerogels during the second quarter worth approximately $145,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.